Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections

被引：3
|
作者：
Pedersen, Rune M. [1 ]
Bang, Line L. [1 ]
Tornby, Ditte S. [1 ]
Madsen, Lone W. [1 ]
Holm, Dorte K. [1 ]
Sydenham, Thomas V. [1 ]
Johansen, Isik S. [1 ]
Jensen, Thoger G. [1 ]
Justesen, Ulrik S. [1 ]
Andersen, Thomas E. [1 ]
机构：
[1] Univ Southern Denmark, Odense, Denmark
来源：
EMERGING INFECTIOUS DISEASES | 2022年 / 28卷 / 12期
关键词：
D O I：
10.3201/eid2812.221304
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Worldwide, millions of persons have received multiple COVID-19 vaccinations and subsequently recovered from SARS-CoV-2 Omicron breakthrough infections. In 2 small, matched cohorts (n = 12, n = 24) in Denmark, we found Omicron BA.1/BA.2 breakthrough infection after 3-dose BNT162b2 vaccination provided improved Omicron BA.5 neutralization over 3-dose vaccination alone.
引用
收藏
页码：2575 / 2577
页数：3
相关论文
共 50 条
  • [1] Serum Neutralization of Omicron BA.5, BA.2 and BA.1 in Triple Vaccinated Kidney Transplant Recipients
    Pedersen, Rune M.
    Bang, Line L.
    Tornby, Ditte S.
    Nilsson, Anna C.
    Nielsen, Christian
    Madsen, Lone W.
    Johansen, Isik S.
    Sydenham, Thomas V.
    Jensen, Thoger G.
    Justesen, Ulrik S.
    Vitved, Lars
    Palarasah, Yaseelan
    Bistrup, Claus
    Andersen, Thomas E.
    [J]. KIDNEY INTERNATIONAL REPORTS, 2023, 8 (03): : 667 - 671
  • [2] BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
    Roessler, Annika
    Netzl, Antonia
    Knabl, Ludwig
    Schaefer, Helena
    Wilks, Samuel H.
    Bante, David
    Falkensammer, Barbara
    Borena, Wegene
    von Laer, Dorothee
    Smith, Derek J.
    Kimpel, Janine
    [J]. NATURE COMMUNICATIONS, 2022, 13 (01)
  • [3] BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
    Annika Rössler
    Antonia Netzl
    Ludwig Knabl
    Helena Schäfer
    Samuel H. Wilks
    David Bante
    Barbara Falkensammer
    Wegene Borena
    Dorothee von Laer
    Derek J. Smith
    Janine Kimpel
    [J]. Nature Communications, 13
  • [4] Impact of BA.1, BA.2, and BA.4/BA.5 Omicron mutations on therapeutic monoclonal antibodies
    Jawad, Bahaa
    Adhikari, Puja
    Podgornik, Rudolf
    Ching, Wai-Yim
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 2023, 167
  • [5] Neutralizing Antibody Response of the Wild-Type/Omicron BA.1 Bivalent Vaccine as the Second Booster Dose against Omicron BA.2 and BA.5
    Kawasuji, Hitoshi
    Morinaga, Yoshitomo
    Tani, Hideki
    Saga, Yumiko
    Yamada, Hiroshi
    Yoshida, Yoshihiro
    Takegoshi, Yusuke
    Kaneda, Makito
    Murai, Yushi
    Kimoto, Kou
    Ueno, Akitoshi
    Miyajima, Yuki
    Nagaoka, Kentaro
    Ono, Chikako
    Matsuura, Yoshiharu
    Niimi, Hideki
    Yamamoto, Yoshihiro
    [J]. MICROBIOLOGY SPECTRUM, 2023, 11 (02):
  • [6] Neutralizing activity against Omicron BA.5 after tixagevimab/cilgavimab administration comparable to those after Omicron BA.1/BA.2 breakthrough infections
    Yang, Jinyoung
    Won, Gunho
    Baek, Jin Yang
    Lee, Young Ho
    Kim, Haein
    Huh, Kyungmin
    Cho, Sun Young
    Kang, Cheol-In
    Chung, Doo Ryeon
    Peck, Kyong Ran
    Lee, Kyo Won
    Park, Jae Berm
    Yoon, Sang Eun
    Kim, Seok Jin
    Kim, Won Seog
    Yim, Min Su
    Kim, Kwangwook
    Hyeon, Seokhwan
    Kim, Byung Chul
    Lee, Yoo-kyung
    Ko, Jae-Hoon
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [7] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tomokazu Tamura
    Daichi Yamasoba
    Yoshitaka Oda
    Jumpei Ito
    Tomoko Kamasaki
    Naganori Nao
    Rina Hashimoto
    Yoichiro Fujioka
    Rigel Suzuki
    Lei Wang
    Hayato Ito
    Yukie Kashima
    Izumi Kimura
    Mai Kishimoto
    Masumi Tsuda
    Hirofumi Sawa
    Kumiko Yoshimatsu
    Yuki Yamamoto
    Tetsuharu Nagamoto
    Jun Kanamune
    Yutaka Suzuki
    Yusuke Ohba
    Isao Yokota
    Keita Matsuno
    Kazuo Takayama
    Shinya Tanaka
    Kei Sato
    Takasuke Fukuhara
    [J]. Communications Biology, 6
  • [8] Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5
    Tamura, Tomokazu
    Yamasoba, Daichi
    Oda, Yoshitaka
    Ito, Jumpei
    Kamasaki, Tomoko
    Nao, Naganori
    Hashimoto, Rina
    Fujioka, Yoichiro
    Suzuki, Rigel
    Wang, Lei
    Ito, Hayato
    Kashima, Yukie
    Kimura, Izumi
    Kishimoto, Mai
    Tsuda, Masumi
    Sawa, Hirofumi
    Yoshimatsu, Kumiko
    Yamamoto, Yuki
    Nagamoto, Tetsuharu
    Kanamune, Jun
    Suzuki, Yutaka
    Ohba, Yusuke
    Tabata, Kaori
    Yokota, Isao
    Matsuno, Keita
    Takayama, Kazuo
    Tanaka, Shinya
    Sato, Kei
    Fukuhara, Takasuke
    [J]. COMMUNICATIONS BIOLOGY, 2023, 6 (01)
  • [9] Neutralization of the SARS-CoV-2 Omicron BA.1 and BA.2 Variants
    Yu, Jingyou
    Collier, Ai-ris Y.
    Rowe, Marjorie
    Mardas, Fatima
    Ventura, John D.
    Wan, Huahua
    Miller, Jessica
    Powers, Olivia
    Chung, Benjamin
    Siamatu, Mazuba
    Hachmann, Nicole P.
    Surve, Nehalee
    Nampanya, Felix
    Chandrashekar, Abishek
    Barouch, Dan H.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (16):
  • [10] A booster of Delta-Omicron RBD-dimer protein subunit vaccine augments sera neutralization of Omicron sub-variants BA.1/BA.2/BA.2.12.1/BA.4/BA.5
    Duan, Minrun
    Duan, Huixin
    An, Yaling
    Zheng, Tianyi
    Wan, Shengfeng
    Wang, Hui
    Zhao, Xin
    Dai, Lianpan
    Xu, Kun
    Gao, George F.
    [J]. EMERGING MICROBES & INFECTIONS, 2023, 12 (01)
12345